Biotech · Private company
Cellenkos, Inc.
Track this companyFree. Adds Cellenkos, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CK0801Phase 1 · Bone Marrow DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CK0802Phase 1 · COVID19ClinicalTrials.gov · fetched Nov 12, 2026
- CK0803Phase 1 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- CK0804Phase 1 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- ExcipientPhase 1 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Regulatory T Cells for Amyotrophic Lateral SclerosisPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 3, 2023ClinicalTrials.gov NCT05695521 · fetched Nov 12, 2026
- Leading in MPNs Beyond Ruxolitinib in Combo With T-RegsPHASE1 · RECRUITING · started Dec 27, 2022ClinicalTrials.gov NCT05423691 · fetched Nov 12, 2026
- REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumoniaPHASE1 · COMPLETED · started Sep 29, 2020ClinicalTrials.gov NCT04468971 · fetched Nov 12, 2026
- A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)PHASE1 · ACTIVE_NOT_RECRUITING · started May 30, 2019ClinicalTrials.gov NCT03773393 · fetched Nov 12, 2026